Skip to main content

Table 2 SPIRIT diagram of study procedures [28,29,30,31,32]

From: Targeted anti-staphylococcal therapy with endolysins in atopic dermatitis and the effect on steroid use, disease severity and the microbiome: study protocol for a randomized controlled trial (MAAS trial)

  1. Visit 1, enrolment in the trial and start of a 2-week run-in phase; visit 2a, start of the intervention (baseline); visit 2b, 0.5 hours after baseline; visit 3, 2 weeks after baseline; visit 4, 6 weeks after baseline; visit 5, 12 weeks after baseline and end of the intervention; visit 6, follow-up visit 20 weeks after baseline. All visits take place plus or minus 2 days from the indicated timeframe. EASI Eczema Area and Severity Index, IGA Investigator’s Global Assessment, Pruritus NRS Pruritus Numerical Rating Scale, POEM Patient Orientated Eczema Measure
Back to article page

Trials

ISSN: 1745-6215